Page last updated: 2024-11-06

glipalamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

glipalamide: an antidiabetic drug; RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID65802
CHEMBL ID2105149
SCHEMBL ID1816058
MeSH IDM0055125

Synonyms (23)

Synonym
spc-703
glipalamide
3-methyl-n-(4-methylphenyl)sulfonyl-3,4-dihydropyrazole-2-carboxamide
w7j490cuhm ,
glipalamidum [inn-latin]
glipalamidum
glipalamida [inn-spanish]
37598-94-0
(+-)-5-methyl-n-(p-tolylsulfonyl)-2-pyrazoline-1-carboxamide
glipalamida
unii-w7j490cuhm
glipalamide [inn]
4,5-dihydro-5-methyl-n-((4-methylphenyl)sulfonyl)-1h-pyrazole-1-carboxamide
glipalamide [who-dd]
(+/-)-5-methyl-n-(p-tolylsulfonyl)-2-pyrazoline-1-carboxamide
glipolamide
spc 703
CHEMBL2105149
SCHEMBL1816058
glipolamide; spc 703
Q27292439
DTXSID80865876
5-methyl-n-(4-methylbenzene-1-sulfonyl)-4,5-dihydro-1h-pyrazole-1-carboxamide

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" There was no statistically significant difference in the pharmacokinetic parameters of SPC-703 after administration of two doses, 25 and 50 mg/kg of the drug."( Pharmacokinetics of a new hypoglycemic agent SPC-703.
Angielski, S; Jakubowski, Z,
)
0.13
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (85.71)18.7374
1990's1 (14.29)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 95.83

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index95.83 (24.57)
Research Supply Index2.64 (2.92)
Research Growth Index4.29 (4.65)
Search Engine Demand Index168.36 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (95.83)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (8.33%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other11 (91.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]